NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/31/2021
Back to search
Official data from USPTO
CIRCADIAN NEUROENDOCRINE RESETTING THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CIRCADIAN NEUROENDOCRINE RESETTING THERAPY
ST13
US500000085037493Class
44
Filing
85037493
Registration
3952824
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/31/2021
Trademark type
Word
Nice classes
44
Filing date
05/13/2010
Registration date
04/26/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/31/2021
Last transaction
08/31/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
01/16/2011
First use in commerce
01/16/2011
Drawing code
4
Owner type
16
Owner location
Tiverton, RI, US
Examiner
SLOAN, CYNTHIA
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
VeroScience LLC
Representatives
Francis J. Duffin WIGGIN AND DANA LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Treatment of obesitylipid disordersmetabolic disorderscardiovascular diseasesdiseases of the immune systemage-related diseasescancerdiseases caused by diabetes such as diabetic neuropathyobesitydyslipidemiahypercholestermiahypertension through the therapy of changing the aberrant phase relationships of specific pacemaker biological clock circadian peak neuronal outputse.g.messaging or transmissionwithin the central nervous system
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/31/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/31/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/30/2021
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
08/24/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
04/23/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/26/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/17/2016
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/17/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/17/2016
ES8R
TEAS SECTION 8 RECEIVED
04/26/2016
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/26/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2011
ALIE
ASSIGNED TO LIE
03/18/2011
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
03/02/2011
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
03/01/2011
IUAA
USE AMENDMENT ACCEPTED
03/01/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/01/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/28/2011
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/23/2011
IUAF
USE AMENDMENT FILED
02/23/2011
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/22/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/31/2010
GNRT
NON-FINAL ACTION E-MAILED
08/31/2010
CNRT
NON-FINAL ACTION WRITTEN
08/31/2010
DOCK
ASSIGNED TO EXAMINER
08/26/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
05/20/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2010
NWAP
NEW APPLICATION ENTERED
05/17/2010
Continuous trademark protection
Get notified about every new filing that threatens CIRCADIAN NEUROENDOCRINE RESETTING THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.